Altria

MO Consumer Staples Market cap $118B as of Sep 14, 2026 16:03 ET S&P 500

Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 30, 2026

Revenue$6.11B +0% year over year

Gross profit$3.82B 63% margin

Operating profit$3.14B 51% margin

Net profit$2.30B 38% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	6.11	100%	+0%
Smokeable products	5.39	88%
Oral tobacco	0.71	12%
All other	0.01	0%
Cost of revenue	−2.29	37%
Gross profit	3.82	63% margin	−1pp
Operating expenses	−0.68	11%	+0pp
Operating profit	3.14	51% margin	−2pp
Interest & other costs	−0.21
Tax	−0.63
Net profit	2.30	38% margin	−1pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	5.43	100%	+3%
Smokeable products	4.76	88%
Oral tobacco products	0.67	12%
All other	<0.01	0%
Cost of revenue	−1.92	35%
Gross profit	3.51	65% margin	+3pp
Operating expenses	−0.55	10%	+0pp
Operating profit	2.96	54% margin	+20pp
Interest & other costs	−0.10
Tax	−0.68
Net profit	2.18	40% margin	+20pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	5.8	100%	−2%
Cost of revenue	−2.2	38%
Gross profit	3.6	62% margin	+2pp
Operating expenses	−2.0	34%	+0pp
Operating profit	1.7	28% margin	−20pp
Interest & other costs	−0.1
Tax	−0.4
Net profit	1.1	19% margin	−32pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	6.1	100%	−3%
Smokeable products	5.4	89%	−3%
Oral tobacco	0.7	11%	−5%
Cost of revenue	−2.3	37%
Gross profit	3.8	63% margin	+2pp
Operating expenses	−0.6	10%	+0pp
Operating profit	3.2	53% margin	+3pp
Interest & other costs	−0.2
Tax	−0.7
Net profit	2.4	39% margin	+2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	6.1	100%	−2%
Smokeable products	5.4	88%
Oral tobacco	0.8	12%
Cost of revenue	−2.3	37%
Gross profit	3.9	63% margin	+4pp
Operating expenses	−0.6	10%	+0pp
Operating profit	3.2	53% margin	+12pp
Interest & other costs	−0.1
Tax	−0.7
Net profit	2.4	39% margin	−22pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 30, 2026 Operating margin 51% Net profit $2.30B	Apr 1 – Jun 30, 2026	Jul 30, 2026	$6.11B	+0%	51%	$2.30B	38%
Q1 FY26 Jan 1 – Mar 31, 2026 reported Apr 30, 2026 Operating margin 54% Net profit $2.18B	Jan 1 – Mar 31, 2026	Apr 30, 2026	$5.43B	+3%	54%	$2.18B	40%
Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 25, 2026 Operating margin 28% Net profit $1.12B	Oct 1 – Dec 31, 2025	Feb 25, 2026	$5.85B	−2%	28%	$1.12B	19%
Q3 FY25 Jul 1 – Sep 30, 2025 reported Oct 30, 2025 Operating margin 53% Net profit $2.38B	Jul 1 – Sep 30, 2025	Oct 30, 2025	$6.07B	−3%	53%	$2.38B	39%
Q2 FY25 Apr 1 – Jun 30, 2025 reported Jul 30, 2025 Operating margin 53% Net profit $2.38B	Apr 1 – Jun 30, 2025	Jul 30, 2025	$6.10B	−2%	53%	$2.38B	39%